EXLS:NASDAQExlService Holdings, Inc. Analysis
Data as of 2026-05-20 - not real-time
$28.97
Latest Price
6/10Risk
Risk Level: Medium
Executive Summary
ExlService delivered an earnings surprise of +8.6% and revenue growth of 13.8% YoY in Q1 2026, with adjusted EPS of $0.58 beating consensus estimates. Revenue now stands at $2.32 billion for the full year, close to analyst forecasts, and operating margins remain healthy at roughly 16%. The company’s cash position of $254 million exceeds its free cash flow generation, while debt-to-equity sits near 67%, reflecting a manageable leverage profile. Technical signals are mixed: the 20‑day SMA (≈30.2) and 50‑day SMA (≈30.4) sit above the current price of $28.97, and MACD is in a bearish crossover, yet the RSI of 42 suggests no immediate over‑sell. The DCF‑derived fair value of $42.66 implies a potential upside of over 40%, and the forward PE of 11.5 is well below the industry average of 38, underscoring significant valuation headroom. Market sentiment is extremely bullish (Fear & Greed Index 89), which may be pricing in optimism ahead of further AI‑driven growth.
Overall, the blend of strong top‑line momentum, attractive valuation metrics, and a stable, low‑beta profile positions EXLS as an appealing buy, while the bearish short‑term technical backdrop and moderate volatility advise a cautious, watchful stance.
Overall, the blend of strong top‑line momentum, attractive valuation metrics, and a stable, low‑beta profile positions EXLS as an appealing buy, while the bearish short‑term technical backdrop and moderate volatility advise a cautious, watchful stance.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 6/10
Key Factors
- Earnings beat and revenue acceleration
- Current price below short‑term moving averages
- Bearish MACD histogram
Medium Term
1–3 yearsPositive
Model confidence: 7/10
Key Factors
- DCF upside of >40% and forward PE advantage
- Sustained revenue growth and expanding AI services
- Stable cash flow and manageable debt levels
Long Term
> 3 yearsPositive
Model confidence: 8/10
Key Factors
- Strong ROE (~28%) and high operating margins
- Increasing demand for data and AI solutions across industries
- Undervalued relative to industry peers with long‑run upside potential
Key Metrics & Analysis
Financial Health
Revenue Growth13.80%
Profit Margin11.66%
P/E Ratio18.5
ROE28.09%
ROA12.16%
Debt/Equity66.86
P/B Ratio5.7
Op. Cash Flow$349.2M
Free Cash Flow$295.1M
Industry P/E38.0
Technical Analysis
TrendBearish
RSI42.6
Support$26.82
Resistance$33.01
MA 20$30.21
MA 50$30.44
MA 200$37.66
MACDBearish
VolumeStable
Fear & Greed Index89.36
Valuation
Fair Value$42.66
Target Price$41.75
Upside/Downside44.11%
GradeUndervalued
TypeGrowth
Risk Assessment
Beta0.56
Volatility39.32%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskLow
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.